Faithward Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Faithward Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Sell	4,415 -38,097	-90%	-$2.19M	0.03%	292
2026 Q1	$10.9M	Buy	42,512 +37,688	+781%	+$2.2M	1.56%	13
2025 Q4	$260K	Buy	4,824 +15	+0.3%	+$722	0.04%	284
2025 Q3	$217K	Sell	4,809 -553	-10%	-$25.8K	0.03%	289
2025 Q2	$248K	Buy	5,362 +507	+10%	+$24.9K	0.04%	239
2025 Q1	$296K	Buy	4,855 +349	+8%	+$20.3K	0.05%	211
2024 Q4	$255K	Sell	4,506 -303	-6%	-$16.9K	0.04%	216
2024 Q3	$249K	Buy	+4,809	New	+$226K	0.04%	238
2024 Q2	–	Sell	-4,894	Closed	-$265K	–	254
2024 Q1	$265K	Buy	+4,894	New	+$249K	0.05%	214
2023 Q2	–	Sell	-4,373	Closed	-$302K	–	274
2023 Q1	$302K	Buy	+4,373	New	+$308K	0.07%	146
2020 Q2	–	Sell	-4,348	Closed	-$242K	–	215
2020 Q1	$242K	Sell	4,348 -40	-0.9%	-$2.44K	0.07%	140
2019 Q4	$282K	Buy	+4,388	New	+$251K	0.07%	137

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Faithward Advisors's BMY Position: Q2 2026 in Review

Faithward Advisors reduced its Bristol-Myers Squibb (BMY) stake by 90% in Q2 2026, selling an estimated $2.19M and leaving 4,415 shares worth $254K. The position accounts for 0.03% of the portfolio, ranked #292.

Faithward Advisors first reported a position in BMY in Q4 2019 and has held it in 12 quarters since. The position peaked at $10.9M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Faithward Advisors held 4,415 shares of Bristol-Myers Squibb worth $254K as of Q2 2026.
Faithward Advisors sold 38,097 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.19M.
Bristol-Myers Squibb made up 0.03% of Faithward Advisors's portfolio in Q2 2026, its #292 holding.
Faithward Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 12 quarters since.
Faithward Advisors's Bristol-Myers Squibb position peaked at $10.9M in Q1 2026.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.